Nephropathic Cystinosis
📧 Sign up to get email alerts when something new happens for Nephropathic Cystinosis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-02-11FDA Approved: PROCYSBI — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for PROCYSBI (cysteamine bitartrate) from Horizon Therapeutics USA, Inc., leading to changes to the …
-
FDA label_change · 2017-12-22FDA Approved: PROCYSBI — Supplemental Application (Horizon Therapeutics USA, Inc.)
The FDA approved a supplemental application for PROCYSBI (cysteamine bitartrate) submitted by Horizon Therapeutics USA, expanding or updatin…